巴西批准中巴合作单剂登革热疫苗上市

Group 1 - Brazil's National Health Surveillance Agency (Anvisa) has officially approved the registration of the Butantan-DV single-dose dengue vaccine produced by the Butantan Institute [1] - The Brazilian government plans to provide the vaccine for free through the Brazilian Public Health System (SUS) starting in 2026 [1] - Butantan-DV is the world's first single-dose vaccine for dengue fever, developed in collaboration with China's WuXi Biologics under the coordination of the Brazilian Ministry of Health [1]